Acadia Pharmaceuticals Inc. is dedicated to improving the lives of patients with neuro-psychiatric and rare diseases. The company has developed FDA-approved drugs for Parkinson’s disease psychosis and Rett syndrome, and is currently focused on treating Prader-Willi syndrome, Alzheimer’s disease psychosis, and other neurological conditions through clinical-stage development efforts.
Acadia Pharmaceuticals is seeking a Manager of Forecasting to support commercial operations for neuroscience or rare disease franchises, collaborating with various functions to establish realistic product performance expectations. The role involves developing annual budget forecasts, analyzing market trends, and creating actionable forecasting models. This is a hybrid position requiring a high degree of accuracy, analytical skills, and effective cross-functional collaboration.
Acadia Pharmaceuticals Inc. is dedicated to improving the lives of patients with neuro-psychiatric and rare diseases. The company has developed FDA-approved drugs for Parkinson’s disease psychosis and Rett syndrome, and is currently focused on treating Prader-Willi syndrome, Alzheimer’s disease psychosis, and other neurological conditions through clinical-stage development efforts.
CFGI